Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

Hedge fund manager and entrepreneur Liang Wenfeng built an AI model on a tight budget despite a US attempt to halt China’s ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trials of drugs designed using AI to start late this year.

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

In this way, it’s similar to models under development by Fei-Fei Li’s company, World Labs, and Israeli startup Decart. DeepMind claims that Genie 2 can generate a “vast diversity of rich 3D ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

With "Mind Evolution" LLMs can use search and genetic algorithms to generate and combine different solutions and find the optimal one.

Mistral, the French AI lab, is working toward an initial public offering, co-founder and CEO Arthur Mensch said in an ...

Google challenges OpenAI with free Gemini 2.0 Flash Thinking model, offering million-token processing, native code execution, and breakthrough performance in math and science benchmarks.